HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors.

Abstract
p38 mitogen-activated protein kinases are key mediators of environmental stress response and are promising targets for treatment of inflammatory diseases and cancer. Numerous efforts have led to the discovery of several potent inhibitors; however, so far no highly selective type-II inhibitors have been reported. We previously identified VPC-00628 as a potent and selective type-II inhibitor of p38α/β with few off-targets. Here we analyzed the chemical building blocks of VPC-00628 that played a key role in achieving potency and selectivity through targeting an inactive state of the kinases induced by a unique folded P-loop conformation. Using a rapid, systematic combinatorial synthetic approach, we identified compound 93 (SR-318) with excellent potency and selectivity for p38α/β, which potently inhibited the TNF-α release in whole blood. SR-318 therefore presents a potent and selective type-II inhibitor of p38α/β that can be used as a chemical probe for targeting this particular inactive state of these two p38 isoforms.
AuthorsSandra Röhm, Benedict-Tilman Berger, Martin Schröder, Apirat Chaikuad, Rob Winkel, Koen F W Hekking, Jorg J C Benningshof, Gerhard Müller, Roberta Tesch, Mark Kudolo, Michael Forster, Stefan Laufer, Stefan Knapp
JournalJournal of medicinal chemistry (J Med Chem) Vol. 62 Issue 23 Pg. 10757-10782 (12 12 2019) ISSN: 1520-4804 [Electronic] United States
PMID31702918 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Organic Chemicals
  • Protein Isoforms
  • Protein Kinase Inhibitors
  • Pyrazoles
  • SR-318
  • VPC-00628
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Organic Chemicals (chemistry, pharmacology)
  • Protein Binding
  • Protein Conformation
  • Protein Isoforms
  • Protein Kinase Inhibitors (pharmacology)
  • Pyrazoles (chemistry, pharmacology)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: